Zurich Cantonal Bank
ARCT icon

Zurich Cantonal Bank’s Arcturus Therapeutics ARCT Stock Holding History

Zurich Cantonal Bank’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-49
Closed -$903 – 2619
2025
Q3 		$903 Hold
49
– – ﹤0.01% 2527
2025
Q2 		$637 Sell
49
-8,370
-99% -$99K ﹤0.01% 2545
2025
Q1 		$89.2K Sell
8,419
-180
-2% -$2.86K ﹤0.01% 2427
2024
Q4 		$146K Sell
8,599
-95
-1% -$1.79K ﹤0.01% 2287
2024
Q3 		$202K Buy
8,694
+846
+11% +$18.1K ﹤0.01% 2102
2024
Q2 		$191K Sell
7,848
-184
-2% -$5.58K ﹤0.01% 2058
2024
Q1 		$271K Buy
8,032
+392
+5% +$13.9K ﹤0.01% 1881
2023
Q4 		$241K Sell
7,640
-387
-5% -$9.2K ﹤0.01% 1978
2023
Q3 		$205K Sell
8,027
-4,754
-37% -$146K ﹤0.01% 1963
2023
Q2 		$367K Buy
12,781
+6,988
+121% +$190K ﹤0.01% 1540
2023
Q1 		$139K Hold
5,793
– – ﹤0.01% 2096
2022
Q4 		$98.2K Buy
5,793
+882
+18% +$15.4K ﹤0.01% 2282
2022
Q3 		$73K Sell
4,911
-27
-0.5% -$453 ﹤0.01% 2426
2022
Q2 		$78K Sell
4,938
-262
-5% -$5.14K ﹤0.01% 2401
2022
Q1 		$140K Sell
5,200
-26
-0.5% -$663 ﹤0.01% 2114
2021
Q4 		$193K Buy
5,226
+1
+0% +$41 ﹤0.01% 2087
2021
Q3 		$250K Sell
5,225
-52
-1% -$2.33K ﹤0.01% 1771
2021
Q2 		$179K Buy
5,277
+117
+2% +$3.96K ﹤0.01% 1874
2021
Q1 		$213K Buy
5,160
+3,061
+146% +$182K ﹤0.01% 1741
2020
Q4 		$91K Buy
2,099
+377
+22% +$25.5K ﹤0.01% 2249
2020
Q3 		$74K Buy
1,722
+936
+119% +$46.5K ﹤0.01% 2111
2020
Q2 		$37K Buy
+786
New +$27.1K ﹤0.01% 2293

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Zurich Cantonal Bank's ARCT Position: Q4 2025 in Review

Zurich Cantonal Bank sold out of Arcturus Therapeutics (ARCT) in Q4 2025, closing a stake of 49 shares — an estimated $903 sold.

Zurich Cantonal Bank first reported a position in ARCT in Q2 2020 and held it in 22 quarters. The position peaked at $367K in Q2 2023. 120 funds tracked by Wall St. Rank hold ARCT as of Q4 2025.

  • Zurich Cantonal Bank reported no remaining Arcturus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 49 Arcturus Therapeutics shares in Q4 2025, an estimated $903.
  • Zurich Cantonal Bank first reported a position in Arcturus Therapeutics in Q2 2020 and held it in 22 quarters.
  • Zurich Cantonal Bank's Arcturus Therapeutics position peaked at $367K in Q2 2023.
  • 120 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2025.

Based on Zurich Cantonal Bank's 13F filing for Q4 2025, filed 27 Jan 2026.